CompanyGraph
At a glance
- Depends onDownstream position: depends on 10 industries, supplies 5
- ScaleMarket cap is $12.66B, above the global median of $1.15B
- FinancialsAltman Z-Score 1.74: grey zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
12.66BUSDvs all stocks (USD)
Revenue (TTM)
1.92BUSDvs all stocks (USD)
Profit Margin
-34.99%Beta
2.05xvs all stocks
52-Week Change
-19.29%vs all stocks
Market Capitalization
12.66BUSDvs all stocks (USD)
Enterprise Value
13.10BUSDvs all stocks (USD)
Forward P/E
22.14xPrice to Sales (TTM)
6.58xPrice to Book (MRQ)
3.88xEnterprise to Revenue
6.81xEnterprise to EBITDA
184.18xGross Margin
30.81%Profit Margin
-34.99%Operating Margin
-15.23%Return on Assets (TTM)
-4.00%Return on Equity (TTM)
-20.11%Revenue (TTM)
1.92BUSDvs all stocks (USD)
Revenue per Share (TTM)
4.51USDUpdated Jul 19, 2026Quarterly Revenue Growth
16.80%Gross Profit (TTM)
1.44BUSDvs all stocks (USD)
EBITDA (TTM)
89.75MUSDvs all stocks (USD)
Net Income (TTM)
-672.73MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
16.84%Operating Cash Flow (TTM)
481.22MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
600.42MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 19, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Minority Interest (Equity)
258.70MUSDFY2025 · Dec 31, 2025Revenue
1.85BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
477.74MUSDFY2025 · Dec 31, 2025Gross Profit
1.37BUSDFY2025 · Dec 31, 2025Operating Income
-479.05MUSDvs all stocks (USD)
Pre-tax Income
-395.20MUSDFY2025 · Dec 31, 2025Income Tax Expense
6.29MUSDFY2025 · Dec 31, 2025Net Income
-401.49MUSDFY2025 · Dec 31, 2025EBIT
-371.19MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
89.75MUSDFY2025 · Dec 31, 2025Research & Development
929.52MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
921.45MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
107.86MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
24.01MUSDFY2025 · Dec 31, 2025EPS (Basic)
-0.9600USDFY2025 · Dec 31, 2025EPS (Diluted)
-0.9600USDFY2025 · Dec 31, 2025Basic Shares Outstanding
420.91MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
420.91MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-401.49MUSDFY2025 · Dec 31, 2025Minority Interests (P&L)
-1.27MUSDFY2025 · Dec 31, 2025Operating Cash Flow
351.43MUSDFY2025 · Dec 31, 2025Free Cash Flow
332.41MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
2.06BUSDFY2025 · Dec 31, 2025Income Tax Paid
10.59MUSDFY2025 · Dec 31, 2025Interest Paid
20.00MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-401.49MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
460.94MUSDFY2025 · Dec 31, 2025Stock-based Compensation
385.21MUSDFY2025 · Dec 31, 2025Other Non-cash Items
-46.43MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-69.08MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
-545.00KUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
22.82MUSDFY2025 · Dec 31, 2025Capital Expenditures
-19.02MUSDFY2025 · Dec 31, 2025Net Intangibles (CF)
-3.00MUSDFY2025 · Dec 31, 2025Purchase of Investments
-2.00MUSDFY2025 · Dec 31, 2025Sale of Investments
0.00USDFY2025 · Dec 31, 2025Net Investing Cash Flow
-21.02MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
690.00MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-641.69MUSDFY2025 · Dec 31, 2025Common Stock Repurchase
0.00USDFY2025 · Dec 31, 2025Other Financing Charges
-57.67MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-9.36MUSDFY2025 · Dec 31, 2025Shares Outstanding
436.40MSharesUpdated Jul 19, 2026Float Shares
357.95MSharesUpdated Jul 19, 2026Shares Short
34.56MSharesUpdated Jul 19, 2026Short Ratio
4.28daysvs all stocks
Short % of Shares Outstanding
7.95%vs all stocks
% Held by Insiders
3.37%vs all stocks
% Held by Institutions
82.25%vs all stocks
Total Cash (MRQ)
2.14BUSDvs all stocks (USD)
Total Cash per Share (MRQ)
4.90USDUpdated Jul 19, 2026Total Debt (MRQ)
2.32BUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.7157xCurrent Ratio (MRQ)
1.95xBook Value per Share (MRQ)
7.48USDUpdated Jul 19, 2026Total Assets
6.84BUSDvs all stocks (USD)
Total Current Assets
2.81BUSDFY2025 · Dec 31, 2025Total Liabilities
3.34BUSDFY2025 · Dec 31, 2025Total Non-current Assets
4.03BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
1.82BUSDFY2025 · Dec 31, 2025Total Current Liabilities
1.53BUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
2.06BUSDFY2025 · Dec 31, 2025Accounts Receivable
643.61MUSDFY2025 · Dec 31, 2025Accounts Payable
13.98MUSDFY2025 · Dec 31, 2025Short-term Debt
556.45MUSDFY2025 · Dec 31, 2025Deferred Revenue
224.41MUSDFY2025 · Dec 31, 2025Long-term Debt
1.68BUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
122.66MUSDFY2025 · Dec 31, 2025Common Stock (Book)
2.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-4.14BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
3.50BUSDvs all stocks (USD)
52-Week Low
16.78USDUpdated Jul 19, 202652-Week High
52.15USDUpdated Jul 19, 202652-Week Change
-19.29%vs all stocks
Beta
2.05xvs all stocks
50-Day MA
28.37USDUpdated Jul 19, 2026200-Day MA
31.76USDUpdated Jul 19, 2026Avg 10-Day Volume
6.63MSharesUpdated Jul 19, 2026Avg 30-Day Volume
7.39MSharesUpdated Jul 19, 2026Diluted EPS (TTM)
-1.57USDUpdated Jul 19, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company growing?
Diagnostic
High R&D Share With Multi-Year Share-Count Growth and Elevated SBC
Heavy R&D and stock pay, with the share count growing across six years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 1.74: grey zoneSignificant
Altman Z-Score: 1.74
Supply Chain
Downstream position: depends on 10 industries, supplies 5Notable
Outgoing: 5.00Incoming: 10.00
High connectivity hub: 15 industry connectionsNotable
Total Connections: 15.00
Scale
Market cap is $12.66B, above the global median of $1.15BNotable
Market cap (USD): 12,655,149,563Global Median: 1,146,734,693.424
Revenue is $1.92B, above the global median of $520.53MNotable
Revenue (USD): 1,922,886,016Global Median: 520,528,949.311
Levered free cash flow is $600.42M, above the global median of $16.24MNotable
Levered free cash flow (USD): 600,423,232Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Godaddy Inc.
Tier 1InterfaceRecurring-Revenue Lock-InFlowProduction
HubSpot, Inc.
Tier 1InterfaceRecurring-Revenue Lock-InProductionFlow
Toast Inc.
Tier 1InterfaceRecurring-Revenue Lock-InFlowProduction
WiseTech Global Limited
Tier 1InterfaceRecurring-Revenue Lock-InProductionFlow
ServiceTitan, Inc.
Tier 1InterfaceRecurring-Revenue Lock-InFlowProduction
Procore Technologies Inc.
Tier 1InterfaceRecurring-Revenue Lock-InFlowSenseMaking
Navan, Inc.
Tier 1InterfaceRecurring-Revenue Lock-InProductionFlow
The Descartes Systems Group Inc.
Tier 1InterfaceRecurring-Revenue Lock-InFlowSenseMaking
Pattern Group Inc.
Tier 1InterfaceRecurring-Revenue Lock-InSenseMakingFlow
Zeta Global Holdings Corp.
Tier 1InterfaceRecurring-Revenue Lock-InAttentionSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
Immunome Inc.
1 interpretationHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBC
Iovance Biotherapeutics, Inc.
1 interpretationHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBC
Abeona Therapeutics Inc.
1 interpretationHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBC